Key facts
- Notable investors include Plug and Play Tech Center, Mirai Cross, FASTAR, Globis University Graduate School of Management, Miraidoa.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Biosono
- ·The full record, as it builds
Funding rounds
No funding rounds for Biosono are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biosono
Manufacturer of wireless stethoscopes intended to create a next-generation medical healthcare environment. The company's device performs primary data processing using an app that utilizes body sound information for multiple uses by releasing apps for each purpose and specification changes can be made on the app side, it can be used flexibly for various purposes such as OEM and research, enabling medical institutions and individuals to create a future sustainable medical and healthcare environment.
- Sector
- Healthcare
- HQ
- Sendai, Japan
- Founded
- 2022
- Website
- biosono.jp/
- Ownership
- Privately Held (backing)
Biosono doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biosono shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biosono in its N-PORT filings yet. We sweep new filings monthly.